Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
06/19/2008 | WO2008073461A2 Ion channel modulators |
06/19/2008 | WO2008072850A1 Triazine derivatives having inhibitory activity against acetyl-coa carboxylase |
06/19/2008 | WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity |
06/19/2008 | US20080146819 (S)-(-)- alpha -ethyl-2-oxo-1-pyrrolidineacetamide; condensation of (S)-2-amino butanol and 4-halobutryl chloride to form alpha -ethyl-2-oxo pyrrolidine ethanol which is oxidized to yield (S)- alpha -ethyl-2-oxo pyrrolidine acetic acid, esterification followed ny ammonification; high yields |
06/19/2008 | US20080146818 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes |
06/19/2008 | US20080146746 a cyclohexyl amine salt of N-substituted succinimide thio group-containing carboxylic acid, used as vulcanization agent or promoters for diene-based or halogenated rubbers |
06/19/2008 | US20080146649 Substituted pyrrolidine and related compounds |
06/19/2008 | US20080146642 Propanesulfonic acid amino acid prodrugs that can deliver 3-amino-1-propanesulfonic acid (3APS) by minimizing metabolism associated with that drug, particularly compounds that block or protect amino group of 3APS such that it avoids metabolism by transaminases or monoamine oxidase; Alzheimer's disease |
06/19/2008 | US20080146632 Fc Receptor Modulating Compounds and Compositions |
06/19/2008 | US20080146607 heterocyclic ketones such as (3-Benzyl-pyrrolidin-3-yl)-(1H-indol-5-yl)-methanone, used as antidepressants or anxiolytic agents |
06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
06/19/2008 | US20080145335 Which protect neural cells from degeneration and/or death in response to injury or disease; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease |
06/19/2008 | CA2668464A1 Materials and methods for co-crystal controlled solid-state synthesis of imides and imines |
06/18/2008 | EP1932851A1 Metal complex, light-emitting material, and light-emitting device |
06/18/2008 | EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
06/18/2008 | EP1931653A2 Therapeutic pyrrolidines |
06/18/2008 | EP1931630A1 N-substituted 3,4-alkylenedioxypyrroles, ester substituted dihydroxypyrroles and methods for synthesis of these pyrroles |
06/18/2008 | EP1931629A1 Sythesis of renin inhibitors involving a cycloaddition reaction |
06/18/2008 | CN101203522A Antineoplastic compounds and pharmaceutical compositions thereof |
06/18/2008 | CN101203508A Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kvl .5 potassium channel blockers and pharmaceutical preparations comprising them |
06/18/2008 | CN101200445A Compound containing bispyrrolidones as well as synthetic method and uses thereof |
06/18/2008 | CN101200444A Method for recovering N-methyl pyrrolidone from exhaust gas and equipment therefor |
06/18/2008 | CN101199537A Hif hydroxylase inhibitors |
06/18/2008 | CN101199512A Hif hydroxylase inhibitors |
06/18/2008 | CN101199503A Hif hydroxylase inhibitors |
06/18/2008 | CN101199502A Hif hydroxylase inhibitors |
06/18/2008 | CN101199501A HIF hydroxylase inhibitors |
06/18/2008 | CN100395236C Piperazine and piperidine derivatives for treatment of neurological diseases |
06/18/2008 | CN100395234C Novel CB1 receptour inverse agonists |
06/18/2008 | CN100395233C N,N-dialkyl-2-pyrrolidone quaternary ammonium salt and its synthesizing method and use |
06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
06/17/2008 | US7388007 2-(3-acetamido-3-isobutyl-2-oxopyrrolidin-1-yl)-N-(3-(3,5-difluorophenyl)-1-hydroxy-1-(4-propoxypyrrolidin-2-yl)propan-2-yl)-4-phenylbutanamide; beta-amyloid peptide inhibitors; neurodegenerative diseases; Alzheimer's Disease, cerebral amyloid angiopathy and Down's Syndrome |
06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
06/17/2008 | CA2286772C Fungicide active substance combinations |
06/12/2008 | WO2008070447A2 Anti-viral compounds |
06/12/2008 | WO2008070305A2 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator |
06/12/2008 | WO2008069313A1 Method for producing pyrrolidine compound |
06/12/2008 | WO2008069168A1 Method for production of 2-hydroxymethylpyrrolidin-3,4-diol or intermediate thereof |
06/12/2008 | WO2008068540A1 New benzamide derivatives as bradykinin antagonists |
06/12/2008 | WO2008068423A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
06/12/2008 | WO2008067873A1 Trifluoromethoxyphenyl-substituted tetramic acid derivatives as pesticides and/or herbicides |
06/12/2008 | WO2008067863A2 Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting mpt |
06/12/2008 | WO2007127639A3 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
06/12/2008 | US20080139854 Process for the preparation of activated polyethylene glycols |
06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
06/12/2008 | US20080139805 Process for producing carbapenem derivative having a 1-alkylpyrrolidine structure |
06/12/2008 | US20080139639 Proton Pump Inhibitors |
06/12/2008 | US20080139625 Pyrrolidin-2-One and Piperidin-2-One Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
06/12/2008 | US20080138704 Material for Electrolytic Solution, Ionic Material-Containing Composition and Use Thereof |
06/12/2008 | CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy |
06/12/2008 | CA2667210A1 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator |
06/11/2008 | EP1930330A1 Pleuromutilin derivatives as antimicrobials |
06/11/2008 | EP1930321A1 Process for preparation of tetrasubstituted 5-azaspiro[2.4]- heptane derivatives and optically active intermediates thereof |
06/11/2008 | EP1930319A1 Proline derivatives and use thereof as drugs |
06/11/2008 | EP1928872A1 Novel sulphonylpyrroles as inhibitors of hdac s novel sulphonylpyrroles |
06/11/2008 | EP1928826A1 Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors |
06/11/2008 | EP1928825A1 Novel cross-linkers for obtaining structure information on molecule complexes |
06/11/2008 | EP1928824A1 Process for annealing amorphous atorvastatin |
06/11/2008 | EP1928823A1 Crystalline and amorphous sodium atorvastatin |
06/11/2008 | EP1928822A1 Violet laser excitable dyes and their method of use |
06/11/2008 | EP1928821A1 Carboxamide derivatives as muscarinic receptor antagonists |
06/11/2008 | EP1928599A2 Lewis acid catalyzed halogenation of activated carbon atoms |
06/11/2008 | EP1638933B1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
06/11/2008 | EP1414794B1 Allylmercaptocaptopril compounds and uses thereof |
06/11/2008 | CN101198583A Compounds which inhibit beta-secretase activity and methods of use |
06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
06/11/2008 | CN101195096A Chirality latex catalyst, production method and application thereof |
06/11/2008 | CN100393722C Inhibitors of nucleoside metabolism |
06/10/2008 | US7385065 Derivatives of N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide; for preparation of drugs |
06/10/2008 | US7384973 Materials and methods for treating hypercholesterolemia |
06/10/2008 | US7384639 Methods of treating or preventing an infectious disease using an immunogenic conjugate of a gram-negative bacterial autoinducer molecule |
06/10/2008 | CA2431068C Crystalline forms of atorvastatin |
06/10/2008 | CA2429590C Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
06/10/2008 | CA2227607C Penicillaminamide derivatives |
06/05/2008 | WO2008066117A1 Cyclic amine compound |
06/05/2008 | WO2008066083A1 Process for production of n-(n'-substituted-glycyl)- 2-cyanopyrrolidine derivative |
06/05/2008 | WO2008011072A3 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
06/05/2008 | WO2007051604A3 Novel 2,4-dichlorophenoxy acetic acid derivatives and use thereof in diagnostic and analytic detection methods |
06/05/2008 | US20080132711 High Molecular Weight Polyamine Salts as Clay Stabilizing Agents |
06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
06/05/2008 | US20080132600 Safe toxicity, fire, storage and explosive profile; free radical polymerization; such as n-imidoester derivatives; infrared, ultraviolet, microwave, convection and/or ultrasound curable coatings |
06/05/2008 | US20080132562 Tetronic and tetramic acids |
06/05/2008 | US20080132561 Materials and Methods for Treating Hypercholesterolemia |
06/05/2008 | US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists |
06/05/2008 | US20080132480 Biphenyloxyacetic Acid Derivatives for the Treatment of Respiratory Disease |
06/05/2008 | US20080132459 Inhibitors of Histone Deacetylase |
06/05/2008 | CA2670976A1 Cyclic amine compound |
06/04/2008 | EP1927588A2 Process for producing optically active azetidine-2-carboxylic acids |
06/04/2008 | EP1927587A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
06/04/2008 | EP1926710A1 4-substituted pyrr0lidin-2-0nes and their use |
06/04/2008 | EP1926709A1 Process for the preparation of chiral 3-hydroxy pyrrolidine compound and derivatives thereof having high optical purity |
06/04/2008 | EP1926708A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation |
06/04/2008 | EP1747198B1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
06/04/2008 | EP1343775B1 Piperazine derivatives |
06/04/2008 | CN101193860A 有机化合物 Organic compounds |
06/04/2008 | CN101193852A Analogs of 4-hydroxyisoleucine and uses thereof |
06/04/2008 | CN101190894A Fatty acid synthetic enzyme inhibitor and medical preparation use thereof |
06/04/2008 | CN100391947C Biphenylcarboxamide compound |